Global Pharmaceuticals & Medicine Manufacturing

IBISWorld
August 29, 2014
36 Pages - SKU: IBSS5345486
Countries covered: Global

Global Pharmaceuticals & Medicine Manufacturing

Over the five years to 2014, the Global Pharmaceuticals and Medicine Manufacturing industry experienced moderate growth. Underpinning this growth has been the rising demand for healthcare and medications worldwide, especially from emerging economies. Higher healthcare standards and greater emphasis on illness prevention have given pharmaceuticals a higher significance among consumers, driving sales over the period. However, the consequences of the credit crisis and subsequent austerity measures implemented by various governments worldwide translated into cuts in healthcare funding. Nonetheless, the industry will continue to grow ascetically over the next five years, with revenue forecast to increase as a result of the world's aging population boosting healthcare demand and expanding emerging markets.

This industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms including ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. The overall pharmaceutical market can be segmented into prescription-based (or ethical) products and over-the-counter medications. Industry products are predominantly distributed via wholesalers, and are then sold via pharmacies or distributed in hospitals.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.


Additional Information

MAJOR COMPANIES

Pfizer Inc.


More Prescription Drugs reports by IBISWorld

Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report by IBISWorld
Brand Name Pharmaceutical Manufacturing in the USWith healthcare reform allowing more individuals to gain prescription coverage, brand-name pharmaceutical and medicine manufacturers will experience a boost ...
Online Pharmaceutical Sales in Australia - Industry Market Research Report by IBISWorld
Online Pharmaceutical Sales in AustraliaCompanies in this industry primarily sell pharmaceutical products via the internet. This includes prescription and non-prescription medicines and associated personal care ...
Pharmacies in Australia - Industry Market Research Report by IBISWorld
Pharmacies in AustraliaThe industry includes all community pharmacies that sell prescription drugs and patent medicines to general consumers. The products are sourced either from pharmaceutical ...
Pharmaceuticals Wholesaling in Australia - Industry Market Research Report by IBISWorld
Pharmaceuticals Wholesaling in AustraliaThe industry comprises companies that wholesale human-use pharmaceutical products, including prescription drugs, over-the-counter medicines and complementary or alternative medicines. It also covers ...
See all reports like this >>

More Global Prescription Drugs reports

Yersinia Pestis Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 by DelveInsight
Yersinia Pestis Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015DelveInsight’s, “Yersinia Pestis Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report ...
Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 by DelveInsight
Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015DelveInsight’s, “Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report ...
Wolff-Parkinson-White Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 by DelveInsight
Wolff-Parkinson-White Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015DelveInsight’s, “Wolff-Parkinson-White Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive ...
Wilms' Tumor (Nephroblastoma)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 by DelveInsight
Wilms' Tumor (Nephroblastoma)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015DelveInsight’s, “Wilms' Tumor (Nephroblastoma)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 1,020  
    Global Site License  USD 2,550  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!